Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company MyoKardia Inc.
DescriptionSmall molecule allosteric modulator of cardiac myosin
Molecular Target Cardiac myosin
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationCardiomyopathy
Indication DetailsTreat hypertrophic cardiomyopathy; Treat non-obstructive hypertrophic cardiomyopathy; Treat symptomatic obstructive hypertrophic cardiomyopathy
Regulatory Designation U.S. - Orphan Drug (Treat symptomatic obstructive hypertrophic cardiomyopathy)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today